Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,399.05 +252.05 (+0.41%) CMC Crypto 200
1,268.19 -89.82 (-6.62%)
GSK Aug 2024 39.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:58PM EDT. Market open.
| Previous close | 5.94 |
| Open | 6.30 |
| Bid | 5.50 |
| Ask | 8.30 |
| Strike | 39.00 |
| Expiry date | 2024-08-16 |
| Day's range | 6.30 - 6.44 |
| Contract range | N/A |
| Volume | |
| Open interest | 314 |
Simply Wall St.GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see GSK plc...
- Simply Wall St.
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
GlobeNewswireBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
© 2024 Yahoo. All rights reserved.